- MINDCURE just announced receiving its HIPAA certification for iSTRYM, its AI-powered, SaaS platform for psychedelic therapy
- This marks a key milestone for the company, having already exceeded its target of 10 partner clinics by the end of 2021
- It also inches the company closer to the platform’s commercial deployment, set for the second quarter of 2022
- This comes just in time, following the appointment of Dr. Doron Sagman as the company’s new CMO
- MINDCURE’s Life Sciences Virtual Conference Presentation will also be available for on-demand viewing 24/7 for the next 90 days
Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) has been at the forefront of the mental health industry, developing digital therapeutics and researching various psychedelic compounds. Such a blend in its approach has placed the company in a unique position to address these medical needs and stamp its position in the market.
In what marks a significant leap towards commercial viability and bringing its products and services even closer to consumers, MINDCURE just announced receiving…
NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
